However, when the p21WAF1/p53 phenotype was taken into account, it was only in the subgroup of patients with colon cancer and an immunophenotype other than p21WAF1+/p53- that TS expression emerged as an important prognostic/predictive marker. Here, TYMS is linked to malignant colon neoplasm.